Study title: A three month, double blind, double dummy, parallel group, controlled study comparing the efficacy and safety between 12 mcg twice daily of Formoterol-HFA and 12 mcg twice daily of Formoterol-DPI (Foradil Aerolizer) in childrem with persistent asthmaStudy report
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases | |||||
Brands: | |||||
MAH holders: | |||||
Assessment: | |||||
Active substance: cur | |||||
ATC code: R03AC13 | |||||
Document link: RA-RS-3301-002-05 (Synopsis).doc | |||||
Document date: 2015-03-02 | |||||
Study number: RA/PR/3301/010/03 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |